May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Enhancement of NAD–Induced Vasotoxicity: An Early Effect of Diabetes on Retinal Microvessels
Author Affiliations & Notes
  • S. Liao
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI
  • D.G. Puro
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI
  • Footnotes
    Commercial Relationships  S. Liao, None; D.G. Puro, None.
  • Footnotes
    Support  NEI Grant EY12505, NEI Grant EY07003, Research to Prevent Blindness, Inc., Fight for Sight Student Fellowship, U. Michigan Summer Biomedical Research Program grant (NIH T–35), Midwest Eye Bank grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1747. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Liao, D.G. Puro; Enhancement of NAD–Induced Vasotoxicity: An Early Effect of Diabetes on Retinal Microvessels . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1747.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : A sight–threatening complication of diabetes is apoptotic cell death in retinal capillaries. In this study, we tested the hypothesis that extracellular NAD+ (nicotinamide adenine dinucleotide) can induce cell death in pericyte–containing retinal microvessels. NAD+ is of interest because it is a putative extracellular signaling molecule in the retina and, from studies of immune cells, is reported to interact with P2X7 purinoceptors whose activation in retinal microvessels can trigger apoptosis.

Methods: : Complexes of pericyte–containing microvessels were freshly isolated from papain–treated adult rat retinas. Cell viability was quantified by trypan blue dye exclusion. Diabetes was induced by streptozotocin–injection.

Results: : In pericyte–containing retinal microvessels, extracellular NAD+ caused cell death in a dose–dependent manner (EC50 = 2 nM). Of importance to diabetes, the NAD+ concentration needed to cause microvascular cell death decreased by ∼40–fold soon after the onset of streptozotocin–induced hyperglycemia. Consistent with NAD’s vasotoxicity being mediated via P2X7 receptor activation, two blockers of these purinoceptors, oxidized–ATP and Brilliant Blue G, dramatically reduced (P = 0.001) the microvascular death caused by NAD+. In addition, cell death induced by NAD+ was prevented (P < 0.001) by pre–exposure to UTP, which in retinal microvessels activates P2Y receptors and blocks the creation of pores formed by P2X7 activation. Indicative of the importance of NAD+ rather than its catabolites, neither ADP–ribose nor nicotinamide were vasotoxic. Suggestive that ecto–ADP–ribosyltransferases (ecto–ARTs) play a key role, pre–incubation of microvessels with a relatively high concentration of etheno–NAD+ (100 µM), which is an ART substrate that does not cause microvascular death, prevented (P = 0.001) NAD+ from inducing vasotoxicity.

Conclusions: : Our findings support the hypothesis that extracellular NAD+ can kill retinal microvascular cells by a mechanism involving the activation of P2X7 purinoceptors. Of further importance, the vulnerability of pericyte–containing retinal microvessels to NAD–induced vasotoxicity was dramatically increased soon after the onset of experimental diabetes.

Keywords: diabetic retinopathy • apoptosis/cell death • vascular cells 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.